CS Paper Radar

Ascent: An Agentic System over the Model Context Protocol for Real-World Clinical Data Analysis

Angelo Ziletti, Leonardo D'Ambrosi, Melanie Tuchardt, Tim Kondziella

cs.AI cs.IR ·submitted 2026-09-21 14:06 UTC · v1
dataset

Abstract

Answering epidemiological questions from real-world clinical data requires medical coding, schema-aware SQL, and validation of implicit choices about populations, denominators, and time. We present Ascent, an agentic system that exposes medical coding, question answering, and cohort analysis through a shared Model Context Protocol tool surface for standardized and native schemas. We introduce EpiTrap, a dataset testing whether systems avoid recognized pharmacoepidemiological errors, and compare a fixed pipeline with agents across models and orchestrators. With capable models, agents improve accuracy over the fixed pipeline by an average of 27 and 20 percentage points on native and standardized schemas, respectively. These gains require more tool calls and longer runtimes. Experience from real projects highlights the system's value for feasibility assessment, diagnostic iteration, and expert-guided analysis.

Closest papers

Nearest neighbours by meaning across the whole index.

ClinVerse: A Realistic Multi-Agent Diagnostic Environment for Training and Evaluating Medical Agents

cs.AI cs.MA ·2026-10-26 ·Sirry Chen, Fangke Chen, Xuanwen Ding, Wei Chen, Zhongyu Wei
similarity 0.74
Abstract

Disease diagnosis is a key application of large language model (LLM) agents in healthcare. However, existing medical agents are primarily trained and evaluated with static question-answering data, providing limited opportunities to learn active information acquisition, examination decision-making, and dynamic clinical interaction. To address this limitation, we present ClinVerse, an interactive, real-data-grounded multi-agent environment designed for training and evaluating medical diagnostic agents. Built on ClinPatient, a scalable dataset comprising 150k diagnostic cases derived from real-world electronic health records, ClinVerse supports coordinated interactions among six specialized clinical roles. Specifically, a doctor agent starts from an initial patient complaint, progressively gathers clinical evidence through patient interviews and examination requests, and ultimately produces a diagnosis. For each interaction trajectory, a rule-based scoring framework quantifies information acquisition, examination ordering, and diagnostic accuracy. These trajectory-level scores serve as reward signals for agent training while also enabling scalable evaluation. In experiments, we evaluate various general-purpose and medical-domain models and show that nine self-evolution methods across three categories consistently improve agents' diagnostic capabilities within ClinVerse. We further analyze the interplay among model capability, environment feedback, and self-evolution methods.

0.13

Large Language Models for Structured Clinical Data Analysis: Dual-Agent Grounding and Validation

cs.AI ·2026-09-28 ·Erfan D. Dehkalani, Seetha Shankaran, Abbot R. Laptook, C. Michael Cotten, P. Ellen Grant +1 more
benchmark similarity 0.73
Abstract · 22 pages, 2 figures

Objective: To develop and characterize CLEAR-Med, a dual-agent framework for natural-language analysis of structured clinical data that separates SQL-based invocation from independent validation. Methods: CLEAR-Med uses one agent to translate a question into executable Structured Query Language (SQL), retain the executed query and database result, and produce a draft. Deterministic checks and a separately invoked cross-provider Validation Agent then accept the draft, request one bounded repair, or abstain. We formalized the system as a bounded selective pipeline and evaluated CLEAR-Med's configuration and scalability, and the Invocation Agent's accuracy and consistency on a 25-query development benchmark, using a harmonized 21-site neonatal hypoxic-ischemic encephalopathy table containing 532 de-identified infant records and approximately 1,300 variables. Results: CLEAR-Med completed all six nominal scalability configurations, including 500x1300. Across 25 development-benchmark queries repeated five times, the Invocation Agent answered 83 of 125 responses correctly (66.4%; query-cluster bootstrap 95% CI, 48.0-83.2%), compared with 15 of 125 (12.0%; 95% CI, 3.2-22.4%) for the ungrounded ChatGPT baseline, a paired improvement of 54.4 percentage points (95% CI, 36.8-72.0%). Conclusion: CLEAR-Med provides a general architecture for traceable analysis of structured clinical data: numerical claims remain linked to executed SQL, and unresolved cases can fail closed. The reported experiments characterize CLEAR-Med's configuration and scalability and the Invocation Agent's accuracy, while the formal analysis establishes the encoded-property guarantee of the complete control flow; a prospective full-pipeline evaluation of the validation and abstention stages is the next stage of this work.

0.17

Sparse Multi-Stage Expert-Agent Routing for Complex Clinical Reasoning

cs.CV ·2026-08-22 ·Sike Xiang, Shuang Chen, Qian sun, Jia Cheng, Yusi Wei +1 more
similarity 0.73
Abstract

Complex clinical reasoning requires models to update diagnostic hypotheses as new evidence emerges and to coordinate different medical specialities under limited consultation resources. Existing LLM-based clinical reasoning systems typically perform single-pass prediction or rely on fixed multi-agent workflows, making expert participation either static or unnecessarily exhaustive. We propose Sparse Multi-Stage Expert-Agent Routing, a language-based clinical reasoning framework that models diagnosis as a stage-wise routing process. Given progressively available clinical evidence derived from multiple modalities, the framework maintains an evolving case state and adaptively activates a sparse set of medical expert agents, supported by expert-specific memory across stages. To evaluate free-text diagnostic conclusions beyond surface similarity, we further introduce ClinFEScore, a fact-aware semantic evaluation protocol for clinical reasoning outputs. On reconstructed multi-stage cases from MAC and AgentClinic-NEJM, our framework reduces the average number of activated experts from 17.0 to 3.0 whilst maintaining strong fact-level diagnostic quality. On 200 real-world hospital MDT cases, ClinFEScore correlates strongly with clinician judgements (Spearman's $ρ=0.81$; Pearson's $r=0.87$), whilst our method achieves 91.5\% clinician-verified diagnostic accuracy with approximately five expert-agent/LLM calls per case. These results support sparse stage-wise coordination as an efficient and clinically relevant approach to LLM-based clinical reasoning.

0.37

ClinAgent: A ReAct-Based Agent for Conversational Access to Clinical Trial Information

cs.AI cs.CLcs.IR ·2026-09-12 ·Antonino Vaccarella, Riccardo Cantini, Domenico Talia, Paolo Trunfio, Marianna Talia +2 more
published similarity 0.71
Abstract · Accepted at the CIBB 2026 conference (https://cibb2026.teralab.ai/)

Querying clinical trial registries remains a manual and error-prone process, requiring researchers to navigate large volumes of semi-structured data without support for natural language interaction or cross-source synthesis. To address this, we introduce ClinAgent, a conversational system based on agentic Retrieval-Augmented Generation (RAG) that enables clinicians and researchers to query clinical trial information in plain language and receive grounded, up-to-date responses across multi-turn interactions. The system centers on a Large Language Model (LLM) agent following the ReAct paradigm, which iteratively reasons over queries, selects among a set of integrated tools, and refines its actions based on intermediate outputs. These tools include a ClinicalTrials.gov search interface, a PubMed module, and a Python-based analyzer operating on a locally cached structured dataset of clinical trials. We evaluate the system using a three-phase framework assessing operational effectiveness, planning quality, tool-use efficiency, and expert qualitative judgments, comparing three LLM backends: Gemini 3.0 Flash and two variants of DeepSeek V3.2 (thinking and non-thinking). Results reveal complementary strengths, with DeepSeek (thinking mode) excelling in planning quality, while Gemini achieves the highest overall performance and strongest expert ratings. Overall, our findings highlight the potential of agentic AI systems to improve the accessibility and synthesis of clinical trial information, supporting more efficient and user-centered biomedical research workflows.

0.29

EMR: Self-Evolving Medical Multi-Agent System via Experience Mining and Reuse

cs.CL cs.AI ·2026-09-14 ·Dongsheng Shi, Yue Li, Xin Yi, Linlin Wang
published similarity 0.69
Abstract

Large language model (LLM) driven multi-agent systems have shown promise in complex clinical reasoning, yet existing approaches rely on static strategies and lack persistent clinical memory, preventing self-evolving from prior diagnostic successes and failures. We present EMR, a self-evolving medical multi-agent system via Experience Mining and Reuse. EMR introduces a hierarchical clinical experience library that organizes accumulated knowledge into three levels: clinical principles, diagnostic patterns, and representative cases. During inference, EMR emulates multidisciplinary consultation: a planner agent coordinates domain-specific department agents for specialized reasoning, while a summary agent synthesizes their analyses into a final decision. Critically, EMR automatically extracts correct diagnostic insights and failure-related warnings from multi-agent reasoning trajectories, incrementally updating the experience library to guide future cases. Experiments on medical reasoning benchmarks demonstrate that EMR consistently outperforms state-of-the-art medical multi-agent baselines. Further analysis reveals that the hierarchical experience enables cross-specialty generalization and transfer across diverse LLM backbones, offering a scalable and in

0.36

The Last Mile of Coding Agents for Long-Document Tasks: An Empirical Study on Clinical Trial Protocol Digitization

cs.CL ·2026-10-13 ·Jiacheng Lin, Geoffrey Low, Nishit Agarwal, Rahul Jain, Afrah Shafquat +2 more
benchmarkcode/data similarity 0.69
Abstract

Clinical trial protocols serve as the source of truth for study design, but are mostly written and used as unstructured PDF documents. Digitizing protocols turns static content into structured, machine-readable data that clinical software can analyze, validate, and execute. Coding agents, which select tools, execute code, and revise their approach as they work, are increasingly applied to such long-document tasks, yet it remains unclear how reliably they turn complete documents into accurate structured outputs. We study this question using protocol digitization as a testbed. We introduce TrialPD-Bench, an expert-annotated benchmark of 150 publicly available protocol PDFs spanning four task categories. Beyond final-answer performance, our evaluation measures evidence recall from agent traces, agent behavior, and cost. Across nine proprietary and open-weight models in five coding-agent harnesses, even the strongest agents do not fully solve protocol digitization. Our analysis further shows that agents usually locate the required evidence but fail in the last mile of transcribing and structuring it. We further develop TrialScribe, a domain-specific harness that equips coding agents with task skills and a verification loop. TrialScribe improves a locally served open-weight model by 6.2-59.4 points across eight metrics, enabling it to match or surpass proprietary models such as GPT-5.6-Sol.

0.35

MARC v1: An Open-Source Multi-Agent Framework for Clinical AI Reasoning and Coordination

cs.AI cs.CL ·2026-08-13 ·Saisha Shetty, Satvik Tripathi, Austin Lin, Colin Zhao, Theodore Kim +4 more
code/data similarity 0.69
Abstract · 13 pages, 4 figures

We present Multi-Agent Reasoning and Coordination (MARC), an open-source framework that replaces monolithic LLM prompting with deterministic multi-agent orchestration for clinical reasoning. MARC coordinates role-specialized agents for extraction, reasoning, answer generation, and evaluation, with explicit context passing and traceable intermediate outputs, enabling stage-wise failure attribution. We additionally introduce a Decomposer module that generates task-specific agent prompts from a plain-language description, eliminating manual prompt engineering. The framework supports both API-based and local CPU-compatible deployments and is entirely configurable via YAML, without code modifications. MARC is designed to be model-agnostic, interpretable, and accessible to clinical domain experts without programming expertise. The full framework is available at https://github.com/Penn-RAIL/MARC-v1.

0.30

MedCaseAgent: From Multimodal Clinical Evidence to Rare Disease Case Reports

cs.AI ·2026-10-23 ·Hongkang Chu, Yifan Shen, Tianjiao Yu, Zhuoqing Zhong, Jianguo Cao +2 more
code/data similarity 0.69
Abstract

Although Large Language Models (LLMs) have demonstrated potential in clinical documentation, generating the rigorous, evidence-based reasoning required for unprecedented, atypical, and rare disease case reports remains a significant challenge. We present MedCaseAgent, an end-to-end agentic reasoning paradigm that bridges this gap by synthesizing publication-quality reports from unstructured clinical notes. MedCaseAgent leverages a hierarchical structure, integrating patient-level data mining with iterative, tool-integrated reasoning. By dynamically querying medical literature and knowledge bases, the agent maintains high clinical fidelity and assesses case novelty. The framework is inherently modular, supporting various backbone LLMs in a plug-and-play fashion. To facilitate this research, we release MedCase-150K, a large-scale multimodal clinical case-report corpus, and MedCase-Bench, a robust temporally held-out evaluation suite. We also introduce an open-source model post-trained from Qwen3.5-9B and optimized specifically for this task. Under both LLM-judged and rule-based evaluation, MedCaseAgent outperforms existing general-purpose and specialized medical LLMs and agents. Blinded expert reviews and ablations further support the system's clinical relevance and evidence grounding.

0.25